OpenVSafe by OpenVAERS
Search V-safe

FNG-23702-79690

5 vaccinations 6 coded responses 40 check-ins 6 free-text entries 1 call case
Sex
Male
Age at first dose
36-40
ZIP prefix
021 / MA
Registered
2020-12-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-26
    Registered in v-safe
  2. 2020-12-26
    Dose 1 — Moderna
  3. 2020-12-26
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site rash, Injection site reaction, Skin lesion — Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Pink nonerythematous nonpruritic patch lesion at injection site/right deltoid
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-28
  7. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  8. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness · Fatigue or tiredness
    Adult check-in
  9. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Fatigue or tiredness
    Adult check-in
  10. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  11. 2021-01-02
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2021-01-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-20
    Dose 2 — Moderna
  14. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  16. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-22
    Dose 3 — Moderna
  28. 2021-10-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Headache, Self-medication — Feeling: Good · Site: Pain
    Free text: Mild headache yesterday, cleared with acetaminophen
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-29
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-05
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-21
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-30
    Survey response — day 35, dose 3
    MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Moderate nasal congestion and runny nose. No fever or chills. No body aches. No cough, no sneezing. Recent travel from Ireland (11/24-11/29) so I started working remotely as a precaution.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-12-03
    Survey response — day 42, dose 3
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-01-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-03-22
    Dose 4 — Pfizer-BioNTech
  40. 2022-04-22
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-09-16
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  42. 2022-10-08
    Survey response — day 21, dose 5
    MedDRA: Cold sweat, Cough, Exposure to SARS-CoV-2, Respiratory symptom, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: URI symptoms of runny nose, dry cough, cold sweats (but no fever) starting 10/1/22. Tested positive via home rapid Covid Test 10/3/22. Likely Covid exposure on 9/30/22 (trip guest with cough)
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-14
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  44. 2022-10-21
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  45. 2022-10-28
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  46. 2022-12-16
    Survey response — 3 months, dose 5
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school
    Free text: COVID infection one week after bivalent vaccination. Mild symptoms only.
    MedDRA releases: 2024-11 · check-in free text available
  47. 2023-03-17
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-26Moderna
22021-01-20Moderna
32021-10-22Moderna No
42022-03-22Pfizer-BioNTech No
52022-09-16Pfizer-BioNTech Flu

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-28

Systemic reaction (other): Pink nonerythematous nonpruritic patch lesion at injection site/right deltoid

Release 10 — days 1–6 daily, dose 3

2021-10-24

Systemic reaction (other): Mild headache yesterday, cleared with acetaminophen

Release 10 — day 35, dose 3

2021-11-30

Symptoms: Moderate nasal congestion and runny nose. No fever or chills. No body aches. No cough, no sneezing. Recent travel from Ireland (11/24-11/29) so I started working remotely as a precaution.

Release 10 — day 42, dose 3

2021-12-03

Symptoms: Nasal congestion

Release 12 — day 21, dose 5

2022-10-08

Symptoms: URI symptoms of runny nose, dry cough, cold sweats (but no fever) starting 10/1/22. Tested positive via home rapid Covid Test 10/3/22. Likely Covid exposure on 9/30/22 (trip guest with cough)

Release 12 — 3 months, dose 5

2022-12-16

Symptoms: COVID infection one week after bivalent vaccination. Mild symptoms only.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCold sweat · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDNasal congestion · · ✓
SDRespiratory symptom · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test positive · · ✓
SROHeadache · · ✓
SROInjection site rash ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓
SROSelf-medication · · ✓
SROSkin lesion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release